Muna Therapeutics

Muna Therapeutics:

Muna Therapeutics, a Copenhagen, Denmark based biopharmaceutical company founded in 2020, is dedicated to discovering and developing transformative therapeutics for neurodegenerative diseases. With a focus on Alzheimer’s, Frontotemporal Dementia, and Parkinson’s, the company aims to combat the devastating impact of these disorders on millions of patients globally. Their pioneering efforts in identifying new medicines to preserve cognition and other brain functions while enhancing resilience to neurodegenerative diseases are captured by their name, Muna, which means 'to remember' in Old Norse. The recent $4.90M grant investment in October 11, 2022 from the Michael J. Fox Foundation underscores the promising potential and innovative approach of Muna Therapeutics in addressing critical unmet medical needs in the field of neurodegenerative diseases. Muna Therapeutics operates within the Biopharma, Biotechnology, and Pharmaceutical industries, positioning itself as a promising player in the quest to develop life-changing therapies for patients suffering from neurodegenerative conditions.